$10.65
-0.38[-3.45%]
At close: Jun 7
$10.65
0[0.00%]
After Hours: 7:53PM EDT
Teladoc Health
(NYSE:TDOC)Teladoc Health Stock (NYSE:TDOC), Analyst Ratings, Price Targets, Predictions
Teladoc Health Inc has a consensus price target of $26.82, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from JP Morgan, B of A Securities, and Wells Fargo on May 21, 2024, May 14, 2024, and April 29, 2024. With an average price target of $14.83 between JP Morgan, B of A Securities, and Wells Fargo, there's an implied 39.28% upside for Teladoc Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
B of A Securities
Wells Fargo
Oppenheimer
TD Cowen
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Teladoc Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/21/2024 | Buy Now | 50.23% | JP Morgan | Lisa Gill | $19 → $16 | Maintains | Neutral | Get Alert |
| 05/14/2024 | Buy Now | 26.76% | B of A Securities | Allen Lutz | $16.5 → $13.5 | Maintains | Neutral | Get Alert |
| 04/29/2024 | Buy Now | 40.85% | Wells Fargo | Stephen Baxter | $17 → $15 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 97.18% | Oppenheimer | Michael Wiederhorn | $26 → $21 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | 40.85% | TD Cowen | Charles Rhyee | $16 → $15 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 31.46% | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | Get Alert |
| 04/26/2024 | Buy Now | 69.01% | RBC Capital | Sean Dodge | $25 → $18 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | 50.23% | Stifel | David Grossman | $21 → $16 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 87.79% | Barclays | Steve Valiquette | $25 → $20 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 134.74% | Canaccord Genuity | Richard Close | $28 → $25 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | — | Needham | Ryan MacDonald | — | Reiterates | → Hold | Get Alert |
| 04/05/2024 | Buy Now | — | Needham | Ryan MacDonald | — | Reiterates | → Hold | Get Alert |
| 03/06/2024 | Buy Now | 59.62% | Truist Securities | Jailendra Singh | $23 → $17 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 106.57% | Cantor Fitzgerald | Sarah James | → $22 | Initiates | → Overweight | Get Alert |
| 02/26/2024 | Buy Now | 59.62% | Leerink Partners | Michael Cherny | → $17 | Initiates | → Market Perform | Get Alert |
| 02/21/2024 | Buy Now | 69.01% | DA Davidson | Gil Luria | $22 → $18 | Maintains | Neutral | Get Alert |
| 02/21/2024 | Buy Now | 78.4% | Citigroup | Daniel Grosslight | $21 → $19 | Maintains | Neutral | Get Alert |
| 02/21/2024 | Buy Now | 134.74% | RBC Capital | Sean Dodge | $30 → $25 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | 134.74% | Barclays | Steve Valiquette | $26 → $25 | Maintains | Overweight | Get Alert |
| 02/21/2024 | Buy Now | 134.74% | Piper Sandler | Jessica Tassan | $30 → $25 | Maintains | Overweight | Get Alert |
| 02/21/2024 | Buy Now | 162.91% | Canaccord Genuity | Richard Close | $34 → $28 | Maintains | Buy | Get Alert |
| 11/17/2023 | Buy Now | 78.4% | JP Morgan | Lisa Gill | $33 → $19 | Maintains | Neutral | Get Alert |
| 10/25/2023 | Buy Now | 181.69% | RBC Capital | Sean Dodge | $35 → $30 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | 144.13% | Oppenheimer | Michael Wiederhorn | $35 → $26 | Maintains | Outperform | Get Alert |
| 10/23/2023 | Buy Now | 97.18% | Citigroup | Daniel Grosslight | $29 → $21 | Maintains | Neutral | Get Alert |
| 10/20/2023 | Buy Now | 97.18% | Citigroup | Daniel Grosslight | $29 → $21 | Maintains | Neutral | Get Alert |
| 09/25/2023 | Buy Now | 162.91% | Truist Securities | Jailendra Singh | → $28 | Reiterates | Hold → Hold | Get Alert |
| 07/26/2023 | Buy Now | 162.91% | Stephens & Co. | Jeff Garro | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/26/2023 | Buy Now | 228.64% | RBC Capital | Sean Dodge | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2023 | Buy Now | 172.3% | Citigroup | Daniel Grosslight | $31 → $29 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Teladoc Health (TDOC)?
The latest price target for Teladoc Health (NYSE: TDOC) was reported by JP Morgan on May 21, 2024. The analyst firm set a price target for $16.00 expecting TDOC to rise to within 12 months (a possible 50.23% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Teladoc Health (TDOC)?
The latest analyst rating for Teladoc Health (NYSE: TDOC) was provided by JP Morgan, and Teladoc Health maintained their neutral rating.
When was the last upgrade for Teladoc Health (TDOC)?
The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.
When was the last downgrade for Teladoc Health (TDOC)?
The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.
When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on May 21, 2024 so you should expect the next rating to be made available sometime around May 21, 2025.
Is the Analyst Rating Teladoc Health (TDOC) correct?
While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $19.00 to $16.00. The current price Teladoc Health (TDOC) is trading at is $10.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.